Corrigendum to “Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database” [Eur J Canc 125, (January 2020) 153–163] (European Journal of Cancer (2020) 125 (153–163), (S0959804919308020), (10.1016/j.ejca.2019.10.030))

Nicolas Delanoy, Anne Claire Hardy-Bessard, Eleni Efstathiou, Sylvestre Le Moulec, Umberto Basso, Alison Birtle, Alastair Thomson, Michael Krainer, Aline Guillot, Ugo De Giorgi, Ali Hasbini, Gedske Daugaard, Amit Bahl, Simon Chowdhury, Orazio Caffo, Philippe Beuzeboc, Dominique Spaeth, Jean Christophe Eymard, Aude Fléchon, Jerome AlexandreCarole Helissey, Mohamed Butt, Frank Priou, Eric Lechevallier, Jean Laurent Deville, Marine Gross-Goupil, Rafael Morales, Antoine Thiery-Vuillemin, Tatiana Gavrikova, Philippe Barthélémy, Avishay Sella, Karim Fizazi, Jean Marc Ferrero, Brigitte Laguerre, Constance Thibault, Sophie Hans, Stéphane Oudard

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Corrigendum to “Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database” [Eur J Canc 125, (January 2020) 153–163] (European Journal of Cancer (2020) 125 (153–163), (S0959804919308020), (10.1016/j.ejca.2019.10.030))'. Together they form a unique fingerprint.

Medicine & Life Sciences